David J Fei-Zhang, Rishabh Sethia, Cyrus W Abrahamson, Olivia K Sosnoski, Anthony M Sheyn, Jill N D'Souza, Daniel C Chelius, Jeffrey C Rastatter
{"title":"美国听神经瘤差异的个体和社区社会决定因素。","authors":"David J Fei-Zhang, Rishabh Sethia, Cyrus W Abrahamson, Olivia K Sosnoski, Anthony M Sheyn, Jill N D'Souza, Daniel C Chelius, Jeffrey C Rastatter","doi":"10.1097/MAO.0000000000004385","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This investigation aims to determine whether community-level social determinants of health (SDoH) influenced acoustic neuroma outcomes more profoundly than individual-level SDoH through the use of multivariate models and census-level socioeconomic status (SES) measures.</p><p><strong>Study design: </strong>Observational, retrospective cohort study. Setting: Specially Authorized Head-Neck SEER 2020 Dataset.</p><p><strong>Patients: </strong>23,330 adult (20+ yr) patients diagnosed with acoustic neuroma from 2010 to 2018.</p><p><strong>Main outcome measures: </strong>Age-adjusted multivariate regressions and hazard models were performed for individual level (sex, race-ethnicity) and community-level factors (Yost Index-SES, rurality-urbanicity) to assess for differences in acoustic neuroma treatment, including delay of intervention, treatment receipt, and overall survival.</p><p><strong>Results: </strong>Lower Yost-SES/community-level SES had a markedly positive association with an increase in all-cause mortality (HR, 1.55; 95% CI, 1.41-1.71) and negative association with stereotactic radiotherapy treatment (OR, 0.93; 95% CI, 0.86-0.99; p = 0.040). Patients with poor Yost-SES had a significantly positive association with receipt of surgical resection (OR, 1.13; 95% CI, 1.07-1.20; p < 0.001).</p><p><strong>Conclusions: </strong>Data generated from this investigation suggest that community-level SDoH, particularly Yost-SES, have more detrimental care and prognostic disparities in acoustic neuroma treatment compared with individual-level factors.</p>","PeriodicalId":19732,"journal":{"name":"Otology & Neurotology","volume":" ","pages":"190-195"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Individual- and Community-Level Social Determinant Associations With Acoustic Neuroma Disparities in the United States.\",\"authors\":\"David J Fei-Zhang, Rishabh Sethia, Cyrus W Abrahamson, Olivia K Sosnoski, Anthony M Sheyn, Jill N D'Souza, Daniel C Chelius, Jeffrey C Rastatter\",\"doi\":\"10.1097/MAO.0000000000004385\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This investigation aims to determine whether community-level social determinants of health (SDoH) influenced acoustic neuroma outcomes more profoundly than individual-level SDoH through the use of multivariate models and census-level socioeconomic status (SES) measures.</p><p><strong>Study design: </strong>Observational, retrospective cohort study. Setting: Specially Authorized Head-Neck SEER 2020 Dataset.</p><p><strong>Patients: </strong>23,330 adult (20+ yr) patients diagnosed with acoustic neuroma from 2010 to 2018.</p><p><strong>Main outcome measures: </strong>Age-adjusted multivariate regressions and hazard models were performed for individual level (sex, race-ethnicity) and community-level factors (Yost Index-SES, rurality-urbanicity) to assess for differences in acoustic neuroma treatment, including delay of intervention, treatment receipt, and overall survival.</p><p><strong>Results: </strong>Lower Yost-SES/community-level SES had a markedly positive association with an increase in all-cause mortality (HR, 1.55; 95% CI, 1.41-1.71) and negative association with stereotactic radiotherapy treatment (OR, 0.93; 95% CI, 0.86-0.99; p = 0.040). Patients with poor Yost-SES had a significantly positive association with receipt of surgical resection (OR, 1.13; 95% CI, 1.07-1.20; p < 0.001).</p><p><strong>Conclusions: </strong>Data generated from this investigation suggest that community-level SDoH, particularly Yost-SES, have more detrimental care and prognostic disparities in acoustic neuroma treatment compared with individual-level factors.</p>\",\"PeriodicalId\":19732,\"journal\":{\"name\":\"Otology & Neurotology\",\"volume\":\" \",\"pages\":\"190-195\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Otology & Neurotology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MAO.0000000000004385\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otology & Neurotology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MAO.0000000000004385","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Individual- and Community-Level Social Determinant Associations With Acoustic Neuroma Disparities in the United States.
Objective: This investigation aims to determine whether community-level social determinants of health (SDoH) influenced acoustic neuroma outcomes more profoundly than individual-level SDoH through the use of multivariate models and census-level socioeconomic status (SES) measures.
Patients: 23,330 adult (20+ yr) patients diagnosed with acoustic neuroma from 2010 to 2018.
Main outcome measures: Age-adjusted multivariate regressions and hazard models were performed for individual level (sex, race-ethnicity) and community-level factors (Yost Index-SES, rurality-urbanicity) to assess for differences in acoustic neuroma treatment, including delay of intervention, treatment receipt, and overall survival.
Results: Lower Yost-SES/community-level SES had a markedly positive association with an increase in all-cause mortality (HR, 1.55; 95% CI, 1.41-1.71) and negative association with stereotactic radiotherapy treatment (OR, 0.93; 95% CI, 0.86-0.99; p = 0.040). Patients with poor Yost-SES had a significantly positive association with receipt of surgical resection (OR, 1.13; 95% CI, 1.07-1.20; p < 0.001).
Conclusions: Data generated from this investigation suggest that community-level SDoH, particularly Yost-SES, have more detrimental care and prognostic disparities in acoustic neuroma treatment compared with individual-level factors.
期刊介绍:
Otology & Neurotology publishes original articles relating to both clinical and basic science aspects of otology, neurotology, and cranial base surgery. As the foremost journal in its field, it has become the favored place for publishing the best of new science relating to the human ear and its diseases. The broadly international character of its contributing authors, editorial board, and readership provides the Journal its decidedly global perspective.